Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer
Tianlei Xie(Nanjing Drum Tower Hospital), Junlong Zhuang(Nanjing Drum Tower Hospital), Minghao Zheng(Zhejiang University), Yao Fu(Illumina (United States)), Shan Peng(Nanjing Drum Tower Hospital), Shujun Liu(Capital Medical University), Meng Ding(Hebei Medical University), Wei Zhao(Chengdu Medical College), Wenli Diao(Nanjing University), Hongqian Guo(Nanjing Drum Tower Hospital)
Cited by 44
Related Papers
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
|New England Journal of Medicine|2023|530
Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma.
|PubMed|1994|485
Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva
|Gynecologic Oncology|1990|430